Scholars@Duke

Astatine-211 labeled Herceptin: An alpha-particle emitting radiotherapeutic.

Publication ,  Conference
Boskovitz, A; Akabani, G; Zhao, XG; Alston, K; Zalutsky, MR
Published in: CLINICAL CANCER RESEARCH
December 1, 2003
Link to item

Duke Scholars

Michael Rod Zalutsky
Author Michael Rod Zalutsky Radiology

Published In

CLINICAL CANCER RESEARCH

ISSN

1078-0432

Publication Date

December 1, 2003

Volume

9

Issue

16

Start / End Page

6189S / 6189S

Location

BOSTON, MASSACHUSETTS

Publisher

AMER ASSOC CANCER RESEARCH

Conference Name

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Boskovitz, A., Akabani, G., Zhao, X. G., Alston, K., & Zalutsky, M. R. (2003). Astatine-211 labeled Herceptin: An alpha-particle emitting radiotherapeutic. In CLINICAL CANCER RESEARCH (Vol. 9, pp. 6189S-6189S). BOSTON, MASSACHUSETTS: AMER ASSOC CANCER RESEARCH.
Boskovitz, A., G. Akabani, X. G. Zhao, K. Alston, and M. R. Zalutsky. “Astatine-211 labeled Herceptin: An alpha-particle emitting radiotherapeutic.” In CLINICAL CANCER RESEARCH, 9:6189S-6189S. AMER ASSOC CANCER RESEARCH, 2003.
Boskovitz A, Akabani G, Zhao XG, Alston K, Zalutsky MR. Astatine-211 labeled Herceptin: An alpha-particle emitting radiotherapeutic. In: CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2003. p. 6189S-6189S.
Boskovitz, A., et al. “Astatine-211 labeled Herceptin: An alpha-particle emitting radiotherapeutic.” CLINICAL CANCER RESEARCH, vol. 9, no. 16, AMER ASSOC CANCER RESEARCH, 2003, pp. 6189S-6189S.
Boskovitz A, Akabani G, Zhao XG, Alston K, Zalutsky MR. Astatine-211 labeled Herceptin: An alpha-particle emitting radiotherapeutic. CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2003. p. 6189S-6189S.

Published In

CLINICAL CANCER RESEARCH

ISSN

1078-0432

Publication Date

December 1, 2003

Volume

9

Issue

16

Start / End Page

6189S / 6189S

Location

BOSTON, MASSACHUSETTS

Publisher

AMER ASSOC CANCER RESEARCH

Conference Name

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis